npj Regenerative Medicine· 2019Q1· Review
Mesenchymal stem cell perspective: cell biology to clinical progress
- 2,028citations
- Q1SCImago
- 2019year
Short summary
Mesenchymal stem cells (MSCs), first described 30 years ago, are multipotent cells with broad anti-inflammatory and immune-modulatory properties, currently under investigation in over 950 clinical trials.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Genetics
GeneticsMedicine